Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.12.16	Valeant Pharmaceuticals Announces Phase 3 Results For Psoriasis Treatment IDP-118 (PR Newswire)
08.12.16	Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST® From Valeant (PR Newswire)
07.12.16	Valeant Pharmaceuticals trade offers a 13.12% return in 226 days, or find similar option trades on Francesca's Holdings Company, Panera Bread Company, General Electric, and Intel (PR Newswire)
07.12.16	Pharming Announces Completion Of Financing for RUCONEST® North American Rights Acquisition (PR Newswire)
05.12.16	Research Reports Initiation on Healthcare Stocks -- Valeant Pharma, Akorn, Universal Health Services, and LifePoint Health (PR Newswire)
30.11.16	Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor (RTTNews)
30.11.16	Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor (RTTNews)
29.11.16	Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor® (PR Newswire)
22.11.16	InvestorsObserver releases covered-call reports for Exelixis, Valeant Pharmaceuticals, Cheniere Energy, General Electric and The Kroger Co (PR Newswire)
22.11.16	Pharming Launches Rights Issue to Raise €12.1 Million as Part of RUCONEST® North American Rights Acquisition Financing (PR Newswire)
21.11.16	Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition (PR Newswire)
18.11.16	Former Valeant Pharma And Philidor Executives Charged In Kickback Scheme (RTTNews)
11.11.16	Valeant Pharmaceuticals Climbing Further Off Multi-Year Low (RTTNews)
08.11.16	Valeant Tumbles On Disappointing Q3 Results, Lower Guidance (RTTNews)
08.11.16	Valeant Pharma Cuts FY16 Forecast As It Slips To Q3 Loss On Charge - Quick Facts (RTTNews)
08.11.16	Valeant To Divest Paragon To Settle FTC Charges (RTTNews)
02.11.16	Valeant Confirms Talks With Third Parties For Various Divestitures (RTTNews)
01.11.16	Valeant Falls On Report Of Possible Criminal Charges (RTTNews)
27.10.16	Biotech Stocks Facing FDA Decision In November (RTTNews)
18.10.16	Valeant Ends Marketing Relationship Pharmacy That Distributed Antidepressant (RTTNews)
14.10.16	Valeant Raises Prices On Certain Products (RTTNews)
07.09.16	Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet (RTTNews)
22.08.16	Valeant Pharma Appoints Paul Herendeen To Succeed Robert Rosiello As CFO (RTTNews)
22.08.16	Valeant Reportedly Appoints Zoetis' Executive Paul Herendeen As CFO (RTTNews)
18.08.16	Valeant Pharma Gets Lender Approval For Amendment To Its Credit Facility (RTTNews)
18.08.16	Valeant Pharma Gets Lender Consent To Amend Credit Facility - Quick Facts (RTTNews)
17.08.16	Valeant Wins Huge Upgrades, Shares Rebound (RTTNews)
11.08.16	Valeant Comments On SDNY Investigation (RTTNews)
11.08.16	WSJ : Valeant Under Criminal Investigation Over Philidor (RTTNews)
09.08.16	Valeant Pharma Q2 Loss Widens On Weak Revenues; Backs FY16 Outlook - Quick Facts (RTTNews)
09.08.16	MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals (RTTNews)
25.07.16	D-Day For TBRA, Nicox Falls As FDA Rejects Vesneo, EXEL Awaits EMA Decision (RTTNews)
22.07.16	Nicox Stock Dips As Partner Bausch + Lomb Of Valeant Gets CRL From FDA (RTTNews)
22.07.16	Valeant Pharma Receives FDA Letter Related To CGMP At Bausch + Lomb Facility (RTTNews)
20.07.16	Valeant Pharmaceuticals Holding On To Notable Gain After Initial Jump (RTTNews)
19.07.16	FDA Advisory Committee Recommends Approval Of Valeant's Brodalumab For Psoriasis (RTTNews)
14.07.16	Valeant Pharma: Former CEO Michael Pearson Trims Ownership Position In Company (RTTNews)
06.07.16	Bausch + Lomb Announces Publication Of Results On LBN Ophthalmic Solution (RTTNews)
01.07.16	AstraZeneca Terminates Valeant's Right On Brodalumab In Europe (RTTNews)
30.06.16	Biotech Stocks Facing FDA Decision In July (RTTNews)
17.06.16	Valeant Announces Investments In Canadian Operations (RTTNews)
15.06.16	Valeant Appoints Thomas Ross As Lead Independent Director (RTTNews)
14.06.16	Report : Valeant Pharma Hires Morgan Stanley To Sell Dermatology Assets (RTTNews)
10.06.16	MRK Opens Wallet, VRX To Face FDA Panel In July, SPHS Vaults On Trial Data (RTTNews)
07.06.16	Valeant Pharma Cuts 2016 Guidance; Posts Loss In Q1 - Quick Facts (RTTNews)
03.06.16	Valeant Pharma Receives Notice Of Default; To File Form 10-Q By June 10 (RTTNews)
27.05.16	WSJ : Valeant Rejected Joint Takeover Approach From Takeda, TPG (RTTNews)
26.05.16	Valeant Names Corporate Controller (RTTNews)
20.05.16	Valeant Pharma Gets Notice Of Default From Bondholders (RTTNews)
18.05.16	Valeant Reportedly Weighs Sale Of Skin, Cancer Drugs (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	534.60	0.68 %	K V
Alcon	77.96	0.44 %	K V
Part Grp Hldg	1’255.00	0.32 %	K V
Novartis	92.16	0.25 %	K V
Swisscom	504.50	0.10 %	K V
Swiss Life Hldg	715.00	-0.61 %	K V
ABB	49.16	-0.77 %	K V
UBS Group	27.52	-0.86 %	K V
Sika	225.90	-1.18 %	K V
Logitech Intl	70.38	-2.22 %	K V

mehr

Valeant Pharmaceuticals International Peer Group Nachrichten

07.06.16		Pharmakonzern Valeant kommt nicht zur Ruhe
20.08.15		Valeant kauft Hersteller von 'Viagra für Frauen'
23.02.15		Pharmakonzern Valeant will Rivalen Salix kaufen

07.06.16

Pharmakonzern Valeant kommt nicht zur Ruhe

20.08.15

Valeant kauft Hersteller von 'Viagra für Frauen'

23.02.15

Pharmakonzern Valeant will Rivalen Salix kaufen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Valeant Pharmaceuticals International

Aktien Top/Flop

Valeant Pharmaceuticals International Peer Group Nachrichten

Meistgelesene Nachrichten